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biosynthesis of menaquinone. Kinetic assays conﬁrmed that plasmodial menaquinone acts at least
in the electron transport. Similarly to Escherichia coli, we observed increased levels of menaquinone
in parasites kept under anaerobic conditions. Additionally, the mycobacterial inhibitor of mena-
quinone synthesis Ro 48-8071 also suppressed menaquinone biosynthesis and growth of parasites,
although off-targets may play a role in this growth-inhibitory effect. Due to its absence in humans,
the menaquinone biosynthesis can be considered an important drug target for malaria.
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Plasmodium falciparum resistance to current drugs used in the
treatment of malaria has led researchers to seek new drug targets,
and the study of pathways localized in an apicoplast is particularly
important in this context. The shikimate pathway and meth-
ylerythritol phosphate pathway (MEP) are localized in this orga-
nelle of P. falciparum [1]. In plants and cyanobacteria these
pathways are the precursors for biosynthesis of phylloquinone
(PhQ) while in bacteria biosynthesizes menaquinone (MQ) [2,3].
Our group demonstrated that the pathway of isoprenoid bio-
synthesis is functionally active in the intraerythrocytic stages of
P. falciparum [4] and that ﬁnal products of this pathway like doli-
chol of 11–12 isoprenic units [5], ubiquinones [6], isoprenylated/
dolichylated proteins [7,8] and carotenoids [9] are biosynthesized
by this parasite when [1-(n)-3H]geranylgeranyl pyrophosphate
was used as a metabolic precursor.
During its intraerythrocytic development in the human host,
the malaria parasite P. falciparum is submitted to considerablechemical Societies. Published by E
f Parasitology, Institute of
eu Prestes 1374, CEP 05508-
.changes in the oxygen concentration due to intermittent cytoad-
herence in the deep vasculature [10], with consequences for the
energy metabolism of the parasite. Facultative anaerobic organ-
isms such as Escherichia coli employ two types of electron carriers,
ubiquinone and menaquinone which are tightly regulated depend-
ing on the oxygen supply in the environment [11].
The present study shows an active pathway for the biosynthesis
of MQ in P. falciparum and shows that MQ could replace the phys-
iological function of ubiquinone (UQ) under anaerobic conditions.
This discovery sheds a new light on the P. falciparum metabolism
and due to its absence in humans; the MQ biosynthesis can be con-
sidered an important drug target against malaria.
2. Materials and methods
2.1. P. falciparum culture
The P. falciparum clone 3D7 was cultured in vitro according to
protocol described by Trager and Jensen [12] where human sera
was substituted by Albumax I (0.5%) [13]. Parasites were grown
in a 40 ml volume under an atmosphere of 5% CO2, 5% O2, and
90% N2 (normal culture). In some experiments parasite were
cultured in anaerobic condition in an atmosphere of 5% CO2 and
95% N2. Parasite development and multiplication were monitored
by microscopic evaluation of Giemsa-stained thin smears. Welsevier B.V. All rights reserved.
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site cultures are not contaminated [14].
2.2. Metabolic labelling
Synchronous cultures of P. falciparum were labelled with [1-
(n)-3H]GGPP (3.125 lCi/ml) (Fig. 1) in normal RPMI 1640 medium
in ring, trophozoite or schizont stages (20% parasitemia) for 12 h
and were then recovered in trophozoite, schizont and ring stages,
respectively. After labelling, ring (1–20 h after reinvasion), tropho-
zoite (20–30 h after reinvasion) and schizont (30–48 h after reinva-
sion) forms were puriﬁed on a 40%/70%/80% discontinuous Percoll
gradient [15] and stored in liquid nitrogen until analysis. Protein
biosynthesis in synchronous cultures of P. falciparum was moni-
tored as described previously [16].
2.3. MQ extraction
Parasites were submitted to MQ extraction following the proto-
col described by Hirauchi et al. [17] or following the protocol de-
scribed by Bekker et al. [18].Fig. 1. Menaquinone biosynthesis pathway. MQs are biosynthesized by the shikimate
derived from chorismate formed via the shikimate pathway. The geranylgeranyl-PP is bio
intraerythrocytic stages of P. falciparumwas indicated. Labelled MQ-4 was characterized i
pyrophosphate was added in culture medium. The [3H] is indicated in bold.2.4. Reversed-phase high performance liquid chromatography
(RP-HPLC)
For both protocols described below the extracts of each parasite
stage obtained frommetabolically labelled parasites were analyzed
with a Phenomenex Luna C18 column (250 mm  4.6 mm  5 lm),
maintained at 28 C. The UV detector was set at 267 nm, and frac-
tions were collected in Gilson HPLC 322 pump (Gilson, Villiers-le-
Bel, France) and also a gradient module connected to a 152 UV–vis-
ible detector, an 831 temperature regulator and an FC203B fraction
collector:
Protocol I – Fractions were collected at 1 min intervals in a iso-
cratic system with methanol:ethanol (95:5, v/v), following the
protocol described by Kamao et al. [19] and extraction protocols
described by Hirauchi et al. [17].
Protocol II – Fractions were collected at 0.5 min intervals in an
isocratic system with methanol:ethanol (50:50, v/v), following
theHPLC and extraction protocols described by Bekker et al. [18].
In all HPLC analysis with samples radioactively labelled we co-
injected with MQ-4 standard. The resulting fractions were driedand methylerythritol phosphate pathway (MEP). The 4-dihydroxy-2-naphthoate is
synthesized by the MEP pathway. The structure of menaquinone-4 (MQ-4) found in
n intraerythrocytic stages of P. falciparumwhen exogenous [1-(n)-3H]geranylgeranyl
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kin Elmer, Turku, Finland) and monitored with a Beckman LS 5000
TB b-counter.
2.5. Mass spectrometry analysis
ESI-MS (electrospray ionization-mass spectrometry) and ESI-
MS/MS (electrospray ionization-tandem mass spectrometry) anal-
ysis were performed using a LCQ-Duo ion-trap mass spectrometer
(ThermoFinnigan, San Jose, CA, USA). For this analysis, 1.0  1010
unlabelled schizont extract were puriﬁed by RP-HPLC (Protocol I)
and the fraction with retention times coincident to the MQ-4 stan-
dard was collected in 2.0 ml plastic tubes, dried in a Speed Vac and
resuspended in 30 ll of chloroform/methanol (1:1, v/v), 2 mM lith-
ium iodide. The MS spectra were acquired in full ion mode and oth-
ers parameters were the same as described [20].
2.6. Inhibition tests with Ro 48-8071
Ro 48-8071 was dissolved in 100% DMSO resulting in 10 mM
stock solutions [21]. We applied the method proposed by Desjar-
dins et al. and Moneriz et al. [22,23] to determine the 50% inhibi-
tory concentrations (IC50 values). The IC50 values for growth
inhibition were calculated by Probit Analysis (Minitab Statistical
Software 13.30 TM; Minitab Inc.). The parasites in schizont stage
were treated with IC50 value of the drug for a total of 48 h and
labelling with [1-(n)-3H]GGPP took place during the last 12 h.
MQ was then extracted [17] and analyzed by HPLC (Protocol II)
[18] to compare the pattern of MQ-4 synthesized by the treated
and untreated parasites.
2.7. MQ biosynthesis in parasites cultivated in anaerobic conditions
The synchronized parasites were maintained in anaerobic con-
ditions for a total time of 48 h. During the last 12 h, parasites were
labelled with [1-(n)-3H]GGPP and then harvested. MQ extraction
and HPLC puriﬁcation techniques were conducted as described
above (Protocol II). The pattern of MQ-4 and UQ biosynthesis from
the parasites submitted to anaerobic conditions was analyzed and
compared to patterns of parasites maintained in normal condition.
Parasites exposed to 48 h in anaerobic conditions were returned
to normal conditions and cultivated for additional 48 h. During the
last 12 h, labelling as before was done and the metabolic proﬁles of
UQ andMQ-4 were analyzed by HPLC (Protocol II) and compared to
control.
2.8. Determination of menaquinone function as a substrate for
electron-carrier in respiratory chain
Free parasites were prepared from aliquots of infected erythro-
cytes (approximately 8  109 cells/ml) by adding 5 volumes of
0.15% (w/v) saponin in phosphate-buffered saline (1.76 mM
K2HPO4, 8.0 mM Na2HPO4, pH 7.4, 137 mM NaCl, 2.7 mM KCl,
5.5 mM D-glucose) for 5 min, followed by three washes by centrifu-
gation and resuspension in HEPES (25 mM)-buffered RPMI and re-
stored in distilled water containing a protease inhibitor cocktail
(Complete Mini; Roche). Cell extracts were prepared by repeated
freeze–thawing in liquid N2, followed by sonication (4 pulses of
15 s at 35 W, on ice). Enzyme activity was measured in a buffered
solution containing 10 mM Tris–HCl, pH 7.4, 50 mM KCl, 1 mM
EDTA, 2 mM KCN, variant concentration of NADH (0–1000 lM)
and 10 lM atovaquone with MQ-4 (200 lM). KCN and atovaquone
were added to avoid the electron ﬂow through the cytochrome sys-
tem (complexes III and IV). The reaction was initiated by the addi-
tion of cell free P. falciparum extract (approximately 500 lg
protein, according to Fisher et al. [24]), and activity was monitoredspectrophotometrically by the decrease in absorbance at 340 nm
(NADH R = 6.22 mM). Enzyme kinetic parameters were calculated
using Enzﬁtter software (Elsevier-Biosoft, Cambridge, UK).3. Results
3.1. Biosynthesis of MQ-4 by the intraerythrocytic stages of
P. falciparum
A radioactive fraction with a retention time coincident with the
MQ-4 standard (11 min) and other non-characterized were de-
tected in all intraerythrocytic stages (Fig. 2A). Higher quantities
of MQ-4 was detected in schizont stages when compared to ring
and trophozoite stages, similarly to what was found for the carot-
enoid synthesis [9].
Other method of extraction [18] and HPLC (Protocol II) analysis
was used to conﬁrm the presence of MQ-4 biosynthesis in schizont
stages of P. falciparum metabolically labelled. Radioactive fraction
with retention time coincident with MQ-4 (14 min) was detected
(Fig. 2B). Other different HPLC methodologies were performed to
conﬁrm the presence of MQ-4 biosynthesis in the parasites (see
Supplementary data). Importantly, no radioactive fractions coin-
ciding with the MQ-4 standard were found in the extracts from
uninfected erythrocytes labelled with [1-(n)-3H]GGPP in all chro-
matographic conditions used (data not shown). Under the above
chromatographic conditions, polyisoprenoids, ubiquinone and
carotenoids have different retention times from the MQ.
The fraction with retention time of 11 min. (HPLC-Protocol I)
corresponding to MQ-4 was collected and analyzed by positive
ion ESI-MS and ESI-MS/MS (Fig. 3). Only the schizont stages were
submitted to mass spectrometry analysis because this stage exhib-
ited the highest levels of MQ-4. In this analysis, identical ionization
proﬁles were observed in the parasite samples and in the standard,
with MQ-4 identiﬁed as [M+Li]+ pseudomolecular ions atm/z ratios
of 451.40. The molecular structure was conﬁrmed by obtaining
matching dissociation patterns when comparing the ESI-MS/MS
spectra of the parental ions with m/z 451.28 from P. falciparum
with the MQ-4 standard, (Fig. 3). Importantly, this compound
was biosynthesized by the parasites since it was not detected by
mass spectrometry either in RPMI or in normal red blood cells used
in the parasite culture (data not shown).
3.2. Ro 48-8071 treatment inhibits the MQ-4 biosynthesis of
P. falciparum cultivated in vitro
The growth of parasites was inhibited in a concentration-
dependent manner (Fig. 4A) with an IC50 value of 4.5 ± 0.3 lM at
48 h of treatment (calculations done as described by Moneriz
et al. [23]). At this IC50, no inhibition of protein biosynthesis was
observed (data not shown). The effect of Ro 48-8071 on MQ-4 bio-
synthesis in the schizont stages was further investigated. The treat-
ment of parasites with Ro 48-8071 signiﬁcantly diminished MQ-4
biosynthesis in 88.2 ± 11%, while UQ increased 30 ± 5% (Fig. 4B).
The inhibition assays were performed in three independent exper-
iments. The inhibitory effect of Ro 48-8071 was not reversed by the
addition of MQ from 1 nM to 1 lM (data not shown).
3.3. Biological function of MQ-4 in P. falciparum
After 10 days under anaerobic conditions, the parasitemia did
not change when compared to control conditions indicating that
the parasite is adapted to growth in anaerobic conditions (data
not shown). Parasites showed an increase of 50 ± 5% in the biosyn-
thesis MQ-4, whereas UQ decreased 15 ± 3% after 48 h in anaerobic
conditions when compared to the controls (Fig. 5A). We then
Fig. 2. Biochemical evidence for the biosynthesis of menaquinone in intraerythrocytic stages of P. falciparum. (A) Proﬁle of RP-HPLC analysis (C18 column, Protocol I) of P.
falciparum extracts [17] from ring, trophozoite and schizont stages (1  109 parasites per stage) metabolically labelled with [1-(n)-3H]GGPP. UNIPOINT™ Software (Gilson
Inc.) was used as the operational and analytical system. Samples were co-injected with MQ-4 standard. (B) The radioactive peaks corresponding to the retention time of UQ
and MQ-4 were plotted from extracts (according to Bekker et al. [18]) of 1  109 schizont stages metabolically labelled with [1-(n)-3H]GGPP, followed by RP-HPLC analysis
(Protocol II). Sample was co-injected with UQ and MQ-4 standards. MQ-4: Menaquinone; UQ: ubiquinone.
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could be reversed in parasites upon reestablishment of normal
conditions. As expected, parasites cultivated for 48 h under anaer-
obic conditions and then shifted to normal conditions for 48 h,
showed the same MQ-4 and UQ levels proﬁle as parasites main-
tained under normal conditions (Fig. 5B).
3.4. P. falciparum menaquinone functions as electron-carrier
The previous assays conﬁrmed the kinetic parameters observed
with decylubiquinone (Km for NADH of 5.1 lM with a Vmax of
0.12 lmol min1 mg1) [24,25]. Menaquinone-dependent NADH
oxidation was measured, and the apparent Km for NADH oxidation
was 72 ± 15 lM with a Vmax of 3 ± 0.8 lmol min1 mg1. Without
MQ-4 or decylubiquinone addition no NADH oxidation was ob-served. The activity was shown to be insensitive to rotenone
(50 lM), the inhibitor of mammalian complex I, but sensitive to
diphenylene iodonium chloride (DPI), a classical Type II
NADH:dehydrogenase inhibitor [26]. Accordingly, DPI inhibited
MQ-4 reduction (data not shown).
4. Discussion
The intraerythrocytic stages of P. falciparum biosynthesizes
MQ-4, and this fact was showed by metabolic labelling with the di-
rect precursor [1-(n)-3H]GGPP. MQ-4 biosynthesized by P. falcipa-
rum was identiﬁed by ﬁve different chromatographic methods
reported for this type of molecule, and conﬁrmed also by ESI-MS/
MS analysis, excluding any uncertainty about the molecular nature
of the detected compound by metabolic labelling. The difference of
Fig. 3. Molecular identiﬁcation of menaquinone biosynthesis in schizont stages of P. falciparum by positive ion ESI-MS and ESI-MS/MS. (A) ESI-MS and ESI-MS/MS analyses of
the MQ-4 standard and unlabelled schizont parasites (1.0  1010) without standard co-injection, both previously puriﬁed by HPLC (Protocol I). The analysis of parasites
sample shows the presence of them/z+ 451.28 ion, coincident with the predicted molecular mass of MQ-4 standard. The molecular structure was conﬁrmed by comparing the
ESI-MS/MS spectra of the parental ions at m/z+ 451.28 from P. falciparum with the standard.
Fig. 4. Menaquinone and Ubiquinone levels change in response to Ro 48-8071 treatment. (A) Ro 48-8071 inhibited parasite growth in a concentration-dependent manner
(IC50 = 4.5 ± 0.3 lM;mean ± S.D., n = 3 experiments), calculated according to Moneriz et al. [23]. (B) Decrease of MQ-4 contents in the schizont stages after the treatment with
4.5 lM of Ro 48-8071. The effect of Ro 48-8071 onMQ biosynthesis was analyzed (by RP-HPLC, Protocol II, with the extraction methodology described by Bekker et al. [18]) as
the relationship between control and Ro 48-8071 treated parasites (2.7  109) metabolically labelled with [1-(n)-3H]GGPP (mean ± S.D., n = 3 experiments). Signiﬁcant
differences comparing control parasites and parasites treated with Ro 48-8071 (One-way ANOVA, P values indicated). UQ: Ubiquinone; MQ-4: menaquinone.
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extraction methods. The recovery of MQ in the extraction following
the protocol described by Hirauchi et al. [17] is higher when com-
pared the protocol described by Bekker et al. [18].The inhibition of parasite growth by Ro 48-8071, an inhibitor of
1,4-dihydroxy-2-naphthoate prenyltransferase, was possibly due
to the inhibition of MQ biosynthesis, although it may be also active
against other targets such as neutral lipid biosynthesis [27]. Also,
Fig. 5. Menaquinone and ubiquinone levels change in response to oxygen supply. (A) The MQ and UQ extracted by the methodology described by Bekker et al. [18]) from
1  109 [1-(n)-3H]GGPP labelled schizonts stages cultivated for 48 h in anaerobic or normal conditions were analyzed by HPLC (Protocol II). The radioactive peaks
corresponding to the retention time of UQ and MQ-4 were plotted. (B) Levels of MQ-4 and UQ from parasites upon reestablishment of normal conditions for 48 h after 48 h
under anaerobic conditions, compared to parasites maintained in normal conditions (n = 3 experiments). Signiﬁcant differences in different oxygen-containing atmospheres
(One-way ANOVA test P values indicated). Control: (5% O2, 5% CO2 and 90% N2); anaerobic: (5% CO2 and 95% N2). UQ: Ubiquinone; MQ-4: menaquinone.
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growth in the presence of Ro 48-8071 could not be observed. This
may point to either a non-competitive type of inhibition in Plasmo-
dium (contrasting to results obtained inMycobacterium tuberculosis
[28]) or an insufﬁcient uptake of external MQ.
In P. falciparum, biochemical data indicate that the mitochon-
drion is not a source of ATP, but instead maintains an active mito-chondrial electron transport chain to serve just one metabolic
function: regeneration of UQ required as the electron acceptor
[29]. Nonetheless, inhibition of cyt bc1 complex electron transport
is lethal to the parasite, presumably by interruption of essential
links to the de novo pyrimidine biosynthesis, dihydroorotate dehy-
drogenase (DHODH) pathway, and to the maintenance of the mito-
chondrial membrane potential. However, Smilkstein et al. [30]
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essential in a drug-selected parasite clone (SB1-A6). They showed
that this clone is pan-resistant to cyt bc1 inhibitors and no muta-
tions were identiﬁed to account for this. One possible explanation
is that DHODH utilizes an alternative readily-available electron
acceptor other than UQ. MQ-4 characterized in this work may
serve as electron acceptor in P. falciparum.
Many respiratory enzymes from E. coli can use both MQ and UQ
as substrate. Different components of the system can be substi-
tuted in the membrane in addition to, or in place of, other compo-
nents as needed: substrate-speciﬁc dehydrogenases; lipoquinones;
and terminal oxidoreductases – all of the dehydrogenases are lipo-
quinone reductases and all of the terminal oxidoreductases are lip-
oquinol oxidases. The lipoquinones involved in the respiratory
chains of bacteria consist of MQs and UQs, while mammals have
only UQ. MQs are the predominant lipoquinones of mycobacteria
and other gram-positive bacteria, whereas gram-negative bacteria
such as E. coli typically utilize both MQ and UQ or solely UQ [31].
Shestopalov et al. showed that E. coli changes the composition of
its quinone pool depending on the aeration conditions and pre-
sented evidence of post-transcriptional regulation of the quinone
biosynthesis [11]. We showed that Type II NADH dehydrogenase
obtained from extracts of P. falciparum can use MQ-4 to oxidize
NADH, and the reaction was functionally isolated from other respi-
ratory complexes by the action of inhibitors of complexes III and
IV. The NADH oxidation by MQ-4 is speciﬁc since without MQ-4
addition no oxidation is observed. The difference observed in the
kinetic parameters from UQ and MQmay be due to that MQ-4 used
in the reaction has a lateral chain with four isoprenic units while
UQ used as a substrate was decylubiquinone, without isoprenic
unit.
P. falciparum can be regarded as microaerophilic [32] during its
asexual intraerythrocytic life cycle. However, living inside a large
body of haemoglobin, it is difﬁcult to predict the exact O2 pressure
to which the parasite is exposed. We showed data that parasites of
P. falciparum change the content of the quinone pools depending
on the aeration condition. However, while the changes in the
MQ/UQ ratios vary in a matter of seconds in E. coli [18] highest dif-
ferences were observed only after the parasites were submitted to
48 h in anaerobic conditions where the levels of MQ increase up to
50% compared to control parasites. At the same time, UQ produc-
tion is decreased by 15% in parasites cultivated in anaerobic condi-
tions. This difference in UQ and MQ contents occurs predominantly
in schizont stages probably because at this time, the parasite usu-
ally resides in an oxygen-depleted environment, sequestered in
deep capillaries. A role for MQ as an electron receptor is also sup-
ported by the observation that through inhibition of MQ synthesis
by Ro 48-8071 a signiﬁcant increase of UQ was observed. This may
be interpreted as an attempt to compensate for an electron accep-
tor loss.
In conclusion, we have shown for the ﬁrst time that P. falcipa-
rum has an active biosynthesis of MQ-4. Its absence in the human
host makes both pathways (MEP and shikimate) very attractive as
potential new target against malaria.
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